Invesco Ltd. Has $82.80 Million Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Invesco Ltd. grew its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,060,263 shares of the company's stock after purchasing an additional 24,392 shares during the period. Invesco Ltd. owned about 2.15% of Prestige Consumer Healthcare worth $82,796,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in PBH. Kestra Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth approximately $27,000. CIBC Private Wealth Group LLC raised its position in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after purchasing an additional 152 shares during the last quarter. Headlands Technologies LLC acquired a new position in Prestige Consumer Healthcare in the fourth quarter worth $40,000. GAMMA Investing LLC boosted its stake in Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock worth $108,000 after purchasing an additional 220 shares in the last quarter. Finally, Huntington National Bank grew its holdings in shares of Prestige Consumer Healthcare by 133.2% during the fourth quarter. Huntington National Bank now owns 1,481 shares of the company's stock worth $116,000 after purchasing an additional 846 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Oppenheimer upped their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Royal Bank of Canada upped their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research report on Friday, March 21st. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. StockNews.com cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. Finally, Canaccord Genuity Group increased their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $93.33.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares of the company's stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Trading Up 0.4 %

PBH stock traded up $0.30 during midday trading on Friday, reaching $80.10. The company's stock had a trading volume of 292,350 shares, compared to its average volume of 286,506. The business's 50-day simple moving average is $84.27 and its 200-day simple moving average is $80.03. The stock has a market cap of $3.97 billion, a PE ratio of 18.76, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.